Results 171 to 180 of about 5,950 (190)

Prescriber profile and postmarketing surveillance

Lancet, The, 1993
Gary Pearce
exaly   +2 more sources

Risk of hypertension in erenumab‐treated patients with migraine: Analyses of clinical trial and postmarketing data

Headache, 2021
David W Dodick, Jessica Ailani
exaly  

ICD Leads and Postmarketing Surveillance

New England Journal of Medicine, 2012
Adam J Mead
exaly  

Characteristics and follow‐up of postmarketing studies of conditionally authorized medicines in the EU

British Journal of Clinical Pharmacology, 2016
Jarno Hoekman, Aukje K Mantel-Teeuwisse, Marie Louise De Bruin   +2 more
exaly  

Postmarketing surveillance of safety and effectiveness of etanercept in Japanese patients with rheumatoid arthritis

Modern Rheumatology, 2011
Masayoshi Harigai, Naoki Ishiguro, Tsutomu Takeuchi   +2 more
exaly  

Safety and effectiveness of adalimumab in Japanese rheumatoid arthritis patients: Postmarketing surveillance report of 7740 patients

Modern Rheumatology, 2014
Naoki Ishiguro, Tsutomu Takeuchi, Hisashi Yamanaka   +2 more
exaly  

Safety and effectiveness of adalimumab in Japanese rheumatoid arthritis patients: postmarketing surveillance report of the first 3,000 patients

Modern Rheumatology, 2012
Masayoshi Harigai, Naoki Ishiguro, Tsutomu Takeuchi   +2 more
exaly  

Safety of Influenza A (H1N1) Vaccine in Postmarketing Surveillance in China

New England Journal of Medicine, 2011
Bao-Ping Zhu
exaly  

Combining multiple healthcare databases for postmarketing drug and vaccine safety surveillance: why and how?

Journal of Internal Medicine, 2014
J Van Der Lei
exaly  

[Publications and postmarketing product surveillance: why and how?].

Annales francaises d'anesthesie et de reanimation, 1998
openaire   +1 more source